What’s the Diagnosis?
From Grahn et al, BJUI 2017
Author Archive for: admin Z.9
Entries by admin Z.9
NICE Guidance: Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated
Overview Evidence-based recommendations on enzalutamide (Xtandi) for treating metastatic, hormone-relapsed prostate cancer for people in whom chemotherapy is not yet clinically indicated. Summary of Appraisal Committee’s Key Conclusions TA377 Appraisal title: Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is clinically indicated Section Key conclusion Enzalutamide is recommended, within its marketing authorisation, as an […]
Article of the Week: Impact of 68Ga-PSMA PET/CT in PCa with rising PSA
Every Week the Editor-in-Chief selects an Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full article, which is freely available to all readers for at least 30 days from the time of this post. In addition to the article itself, […]
What’s the Diagnosis?
From Grahn et al, BJUI 2017
Article of the Week: Introduction of RARC within an established enhanced recovery programme
Every Week the Editor-in-Chief selects an Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full article, which is freely available to all readers for at least 30 days from the time of this post. In addition to the article itself, […]
What’s the Diagnosis?
Images from Grahn et al, BJUI 2017
Article of the Month: Nocturia Increases Depressive Symptoms
Every Week the Editor-in-Chief selects an Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full article, which is freely available to all readers for at least 30 days from the time of this post. In addition to the article itself, […]
What’s the Diagnosis?
This diagram is taken from a recent article in the translational science section – Hsi et al, BJUI 2017.
Article of the Week: Risk prediction tool for grade re-classification in men with favourable-risk prostate cancer on active surveillance
Every Week the Editor-in-Chief selects an Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full article, which is freely available to all readers for at least 30 days from the time of this post. In addition to the article itself, […]
Video: Risk prediction tool for grade re-classification in men with favourable-risk prostate cancer on active surveillance
Risk prediction tool for grade re-classification in men with favourable-risk prostate cancer on active surveillance Abstract Objective To create a nomogram for men on active surveillance (AS) for prediction of grade re-classification (GR) above Gleason score 6 (Grade group >2) at surveillance biopsy. Patients and Methods From a cohort of men enrolled in an AS […]